Supporting these in vitro observations, in pancreatic cancer samples, KLF4 correlated positively with E-cadherin and negatively with vimentin and Cav-1, a direct transcriptional target of KLF4 that can inhibit EMT in pancreatic cancer [81]. This evidence concerns the gene KLF4 and pancreatic neoplasm.